Jason Hulse Murray Sells 23,072 Shares of PACS Group (NYSE:PACS) Stock

PACS Group, Inc. (NYSE:PACS) CEO Jason Murray sold 23,072 shares of the company’s stock in a transaction that occurred on Friday, September 4th. The shares were sold at an average price of $42.69, for a total value of $984,943.68. Following the sale, the chief executive officer owned 54,603,681 shares in the company, valued at approximately $2,331,031,141.89. This trade represents a 0.04% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jason Hulse Murray also recently made the following trade(s):

• On Wednesday, September 9th, Jason Murray sold 4,758 shares of PACS Group stock. The stock was sold at an average price of $43.33, for a total transaction of $206,164.14.
• On Tuesday, September 8th, Jason Murray sold 24,057 shares of PACS Group stock. The shares were sold at an average price of $43.49, for a total transaction of $1,046,238.93.
• On Thursday, September 3rd, Jason Murray sold 20,173 shares of PACS Group stock. The stock was sold at an average price of $42.56, for a total transaction of $858,562.88.
• On Wednesday, September 2nd, Jason Murray sold 23,783 shares of PACS Group stock. The stock was sold at an average price of $42.94, for a total value of $1,021,242.02.
• On Tuesday, September 1st, Jason Murray sold 24,157 shares of PACS Group stock. The stock was sold at an average price of $42.39, for a total value of $1,024,015.23.
• On Friday, August 21st, Jason Murray sold 59,244 shares of PACS Group stock. The shares were sold at an average price of $43.90, for a total transaction of $2,600,811.60.
• On Thursday, August 20th, Jason Murray sold 91,306 shares of PACS Group stock. The shares were sold at an average price of $43.92, for a total value of $4,010,159.52.
• On Wednesday, August 19th, Jason Murray sold 84,717 shares of PACS Group stock. The stock was sold at an average price of $44.26, for a total value of $3,749,574.42.
• On Tuesday, August 18th, Jason Murray sold 66,797 shares of PACS Group stock. The shares were sold at an average price of $44.18, for a total transaction of $2,951,091.46.
• On Monday, August 17th, Jason Murray sold 84,602 shares of PACS Group stock. The shares were sold at an average price of $44.16, for a total transaction of $3,736,024.32.

PACS Group Stock Up 0.4%

Shares of NYSE PACS opened at $44.77 on Friday. PACS Group, Inc. has a 12-month low of $8.00 and a 12-month high of $49.49. The stock’s fifty day simple moving average is $44.74 and its two-hundred day simple moving average is $39.05. The stock has a market capitalization of $7.08 billion, a PE ratio of 26.03, a price-to-earnings-growth ratio of 1.39 and a beta of -0.13. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.21.

PACS Group (NYSE:PACS) last announced its earnings results on Tuesday, August 4th. The company reported $0.63 EPS for the quarter, topping analysts’ consensus estimates of $0.54 by $0.09. PACS Group had a net margin of 4.85% and a return on equity of 29.55%. The business had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.41 billion. As a group, analysts expect that PACS Group, Inc. will post 2.13 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on PACS. Oppenheimer upped their price target on shares of PACS Group from $48.00 to $57.00 and gave the company an “outperform” rating in a research note on Monday, August 10th. Weiss Ratings lowered PACS Group from a “hold (c+)” rating to a “hold (c)” rating in a research report on Wednesday, August 5th. Royal Bank Of Canada raised their target price on PACS Group from $52.00 to $57.00 and gave the company an “outperform” rating in a research report on Thursday, August 6th. Wall Street Zen lowered shares of PACS Group from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 8th. Finally, Zacks Research raised PACS Group from a “hold” rating to a “strong-buy” rating in a report on Monday, August 10th. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $58.80.

Institutional Investors Weigh In On PACS Group

A number of institutional investors have recently made changes to their positions in PACS. Principal Financial Group Inc. purchased a new stake in PACS Group during the 1st quarter worth approximately $3,171,000. Smith Group Asset Management LLC acquired a new stake in PACS Group in the first quarter valued at $771,000. Maven Securities LTD acquired a new stake in shares of PACS Group during the 4th quarter worth about $960,000. BI Asset Management Fondsmaeglerselskab A S purchased a new stake in shares of PACS Group during the 1st quarter worth approximately $6,762,000. Finally, Corient Private Wealth LLC lifted its position in PACS Group by 29.7% in the fourth quarter. Corient Private Wealth LLC now owns 170,052 shares of the company’s stock valued at $6,528,000 after acquiring an additional 38,956 shares during the last quarter.

PACS Group Company Profile

PACS Group, Inc is a U.S. healthcare services company that operates skilled nursing and post-acute care facilities. Its facilities provide short-term rehabilitation, long-term skilled nursing, nursing care, and related clinical services for patients recovering from illness, injury, surgery, or hospitalization.

The company’s broader care offerings may include assisted living, memory care, behavioral health, and other specialized post-acute services, depending on the facility and market.